GSK to publish clinical trial data for drugs

Pharmaceutical giant shocks medical world by opting to reveal findings of all tests on patients

Britain’s largest pharmaceutical company has stunned the medical world by announcing it would back a campaign to publish all clinical trial results to preserve the safety of medicines.

GlaxoSmithKline (GSK) announced the move eight months after it was hit with a record $3bn (£1.9bn) fine in the US last July, in part for withholding safety data about its best selling diabetes drug, Avandia.

In all, 26 drug companies – including eight of the 10 biggest global players – have racked up fines of more than $11bn (£7bn) in the last three years after having been found to have acted dishonestly.

The results of clinical trials, most of which are funded by the drug industry, are frequently withheld when they deliver disappointing results. This distorts the evidence base and raises doubts about the safety of medicines that are available on the market.

GSK said in a statement it would sign up to the alltrials.net campaign which is seeking the registration of all clinical trials, the reporting of all summary results and for full Clinical Study Results – the detailed findings – to be made public.

Campaign organisers who include Ben Goldacre, best-selling author of Bad Pharma, Fiona Godlee, editor of the British Medical Journal and Sir Iain Chalmers, co-founder of the Cochrane Library, said it was a “cartwheel moment.” Dr Goldacre said he had met Andrew Whitty, chief executive of GSK, last week.

“It was clear they have spent a lot of time thinking about these issues. While I will always wait for proof of the pudding I do not believe this is mere lip service,” Dr Goldacre said.

“There is no serious defence for withholding information about clinical trials from doctors and patients. It is simply unethical and it harms patients.”

Observers said GSK had occupied the moral high ground by its move and rival firms would likely follow suit.

The alltrials.net campaign has grown rapidly since publication of Bad Pharma four months ago, winning the backing of the Medical Research Council and the Wellcome Trust. The Commons Science and Technology Committee has announced an inquiry into missing trials.

The latest target of the campaigners is the Swiss multinational Roche, which has been accused by the British Medical Journal of sitting on trial data for its flu treatment, Tamiflu, which governments around the world have stockpiled against a possible pandemic at a cost of billions of pounds.

GSK also said it intends to publish details of trials for all approved  medicines dating back to its formation in 2000.

News
Russell Brand was in typically combative form during his promotional interview with Newsnight's Evan Davis
peopleReports that Brand could stand for Mayor on an 'anti-politics' ticket
News
The clocks go forward an hour at 1am on Sunday 30 March
news
Arts and Entertainment
The Doctor finds himself in a forest version of London in Doctor Who episode 'In the Forest of the Night'
TVReview: Is the Doctor ever going stop frowning? Apparently not.
News
Voluminous silk drawers were worn by Queen Victoria
newsThe silk underwear is part of a growing trade in celebrity smalls
PROMOTED VIDEO
Life and Style
ebooksA superb mix of recipes serving up the freshest of local produce in a delicious range of styles
Life and Style
ebooksFrom the lifespan of a slug to the distance to the Sun: answers to 500 questions from readers
Sport
footballMatch report: Real fight back to ruin Argentinian's debut
News
Candidates with surnames that start with an A have an electoral advantage
newsVoters are biased towards names with letters near start of alphabet
Arts and Entertainment
Isis with Lord Grantham (Hugh Bonneville)
TV
Arts and Entertainment
Jay James
TVReview: Performances were stale and cheesier than a chunk of Blue Stilton left out for a month
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Maths Teacher

    £110 - £200 per day: Randstad Education Leeds: Secondary Maths Teacher for spe...

    Business Analyst - Surrey - Permanent - Up to £50k DOE

    £40000 - £50000 Per Annum Excellent benefits: Clearwater People Solutions Ltd:...

    ***ASP.NET Developer - Cheshire - £35k - Permanent***

    £30000 - £35000 Per Annum Excellent benefits: Clearwater People Solutions Ltd:...

    ***Solutions Architect*** - Brighton - £40k - Permanent

    £35000 - £40000 Per Annum Excellent benefits: Clearwater People Solutions Ltd:...

    Day In a Page

    Wilko Johnson, now the bad news: musician splits with manager after police investigate assault claims

    Wilko Johnson, now the bad news

    Former Dr Feelgood splits with manager after police investigate assault claims
    Mark Udall: The Democrat Senator with a fight on his hands ahead of the US midterm elections

    Mark Udall: The Democrat Senator with a fight on his hands

    The Senator for Colorado is for gay rights, for abortion rights – and in the Republicans’ sights as they threaten to take control of the Senate next month
    New discoveries show more contact between far-flung prehistoric humans than had been thought

    New discoveries show more contact between far-flung prehistoric humans than had been thought

    Evidence found of contact between Easter Islanders and South America
    Cerys Matthews reveals how her uncle taped 150 interviews for a biography of Dylan Thomas

    Cerys Matthews on Dylan Thomas

    The singer reveals how her uncle taped 150 interviews for a biography of the famous Welsh poet
    DIY is not fun and we've finally realised this as a nation

    Homebase closures: 'DIY is not fun'

    Homebase has announced the closure of one in four of its stores. Nick Harding, who never did know his awl from his elbow, is glad to see the back of DIY
    The Battle of the Five Armies: Air New Zealand releases new Hobbit-inspired in-flight video

    Air New Zealand's wizard in-flight video

    The airline has released a new Hobbit-inspired clip dubbed "The most epic safety video ever made"
    Pumpkin spice is the flavour of the month - but can you stomach the sweetness?

    Pumpkin spice is the flavour of the month

    The combination of cinnamon, clove, nutmeg (and no actual pumpkin), now flavours everything from lattes to cream cheese in the US
    11 best sonic skincare brushes

    11 best sonic skincare brushes

    Forget the flannel - take skincare to the next level by using your favourite cleanser with a sonic facial brush
    Paul Scholes column: I'm not worried about Manchester United's defence - Chelsea test can be the making of Phil Jones and Marcos Rojo

    Paul Scholes column

    I'm not worried about Manchester United's defence - Chelsea test can be the making of Jones and Rojo
    Frank Warren: Boxing has its problems but in all my time I've never seen a crooked fight

    Frank Warren: Boxing has its problems but in all my time I've never seen a crooked fight

    While other sports are stalked by corruption, we are an easy target for the critics
    Jamie Roberts exclusive interview: 'I'm a man of my word – I'll stay in Paris'

    Jamie Roberts: 'I'm a man of my word – I'll stay in Paris'

    Wales centre says he’s not coming home but is looking to establish himself at Racing Métro
    How could three tourists have been battered within an inch of their lives by a burglar in a plush London hotel?

    A crime that reveals London's dark heart

    How could three tourists have been battered within an inch of their lives by a burglar in a plush London hotel?